Table 1.
T0° | T1° | T2° | T3° | T4° | |
---|---|---|---|---|---|
First week | 3 months | 6 months | 9 months | 12 months | |
Informed consent | ✓ | ||||
Inclusion and exclusion criteria | ✓ | ||||
Clinical history | ✓ | ||||
Fugl-Meyer Assessment | ✓ | ✓ | ✓ | ✓ | ✓ |
Oxford Cognitive Screen | ✓ | ✓ | ✓ | ✓ | ✓ |
Barthel Index | ✓ | ✓ | ✓ | ✓ | ✓ |
Volumetric analysis of the stroke | ✓ | ||||
Side and site of stroke | ✓ | ||||
DTI | ✓ | ||||
fMRI | ✓ | ✓ | |||
MEP and cortical excitability to TMS | ✓ | ✓ | |||
SSEP | ✓ | ✓ | |||
EEG | ✓ | ✓ | |||
MFI | ✓ | ✓ | |||
DEXA | ✓ | ||||
Microbiota | ✓ | ||||
Biochemistry and miRNA analysis | ✓ | ✓ | |||
Usual care | ✓ | ✓ | ✓ | ✓ | ✓ |
Intensive self-rehabilitation program | ✓ | ✓ | ✓ | ✓ | ✓ |
Physiatric evaluation | ✓ | ✓ | ✓ | ✓ | ✓ |
Video analysis and energetic cost of the gait | ✓ | ✓ | ✓ | ✓ | ✓ |
Psychological evaluation scales | ✓ | ✓ | ✓ | ✓ | ✓ |
Informed consent | ✓ | ✓ | ✓ | ✓ | ✓ |
DTI, Diffusion Tensor Imaging; fMRI, functional Magnetic Resonance Image; MEP, Motor evoked potential; SEP, Somatosensory evoked potential; TMS, Transcranial Magnetic Stimulation; EEG, Electroencephalography; MFI, Multidimensional Fatigue Inventory; DEXA, Dual X-ray Absorptiometry; miRNA, microRNA. °Time from the enrollment.